| 000 | 01640 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513190054.0 | ||
| 264 | 0 | _c19991222 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0301-0147 | ||
| 024 | 7 |
_a10.1159/000022432 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBots, M L | |
| 245 | 0 | 0 |
_aResponse to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study. _h[electronic resource] |
| 260 |
_bHaemostasis _c |
||
| 300 |
_a209-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aActivated Protein C Resistance _xcomplications |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDementia _xepidemiology |
| 650 | 0 | 4 |
_aDementia, Vascular _xgenetics |
| 650 | 0 | 4 |
_aFactor V _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _avan Kooten, F | |
| 700 | 1 | _aBreteler, M M | |
| 700 | 1 | _aSlagboom, P E | |
| 700 | 1 | _aHofman, A | |
| 700 | 1 | _aHaverkate, F | |
| 700 | 1 | _aMeijer, P | |
| 700 | 1 | _aKoudstaal, P J | |
| 700 | 1 | _aGrobbee, D E | |
| 700 | 1 | _aKluft, C | |
| 773 | 0 |
_tHaemostasis _gvol. 28 _gno. 3-4 _gp. 209-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000022432 _zAvailable from publisher's website |
| 999 |
_c10378075 _d10378075 |
||